Mainstay Medical receives Australian approval for neurostimulation implant

Written by Alan Condon | December 06, 2019 | Print  |

The Australian Therapeutic Goods Administration provided regulatory approval for Mainstay Medical's ReActiv8 system.

Three insights:

1. ReActiv8 is restorative neurostimulation implant used to treat chronic lumbar pain.

2. The implant stimulates nerves that supply the lumbar multifidus muscle to generate contraction of the muscle, which can help patients recover from chronic lumbar pain.

3. Mainstay Medical aims to have ReActiv8 included in the Australian Prostheses List for private reimbursement in the third quarter of 2020.

More articles on devices:
9 spine, orthopedic surgeons performing surgeries on international medical missions
Minnesota hospital expands neurosurgery capabilities with 3 OR surgical suite, MRI machine
Meet the new president of Orthofix's global spine business: Kevin Kenny

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers